Engineered Virus-Mimicking Nanovaccine with Lymph Node-Tumor Dual-Targeting and STING-activating Capacity for Robust Cancer Immunotherapy
JOURNAL OF CONTROLLED RELEASE(2025)
Key words
cancer immunotherapy,cancer vaccine,STING agonist,Dual-targeting,Tumor microenvironment
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined